← Open Payments lookup

JOHN LEICHNER: Open Payments

NPI 1225072192 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$158 in 8 payments from 5 companies in 2025. Trend: 2023 $195 · 2024 $96 · 2025 $158

Food & beverage: $158
CompanyPaymentsAmount
Novo Nordisk Inc3$65
ABBVIE INC.2$31
Luye Pharma (USA) Ltd.1$25
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$19
Exact Sciences Corporation1$17

Products named: LINZESS, ERZOFRI EXTENDED-RELEASE, Wegovy, Rybelsus, Ozempic, XIFAXAN, Cologuard Collection Kit.

Industry payments across PA — which companies pay providers there.